Atlas Trials

Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM

Clinical trial NCT07209241 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07209241
Sponsor
University of Pennsylvania
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Glioblastoma
Start date
2025-12-03
Primary completion
2042-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.